In conclusion, our hiPSC-based system represents the first humanized model of GATA2 deficiency that enables the study of endogenously acquired oncogenic mutations, uncovering key chromatin alterations that drive MDS-associated pathology. Here, GATA2 is linked to hyperinsulinemic hypoglycemia, familial, 4.